New layer of the human cornea discovered

Article

Researchers at the University of Nottingham, UK, have announced their discovery of a previously undetected layer in the cornea, the clear window at the front of the human eye.

Researchers at the University of Nottingham, UK, have announced their discovery of a previously undetected layer in the cornea, the clear window at the front of the human eye.

This research has been published in the journal Ophthalmology and could potentially lead the way to improved outcomes for patients requiring corneal transplants and grafts.

The layer will be called Dua’s layer after its discoverer Professor Harminder Dua and is located at the back of the cornea, between the corneal stroma and Descemet’s membrane.

“This is a major discovery that will mean that ophthalmology textbooks will literally need to be re-written. Having identified this new and distinct layer deep in the tissue of the cornea, we can now exploit its presence to make operations much safer and simpler for patients,” Professor Dua commented. “From a clinical perspective, there are many diseases that affect the back of the cornea, which clinicians across the world are already beginning to relate to the presence, absence or tear in this layer.”

The existence of this layer was proven through simulation of human corneal transplants and grafts on eyes donated for research. To do this the researchers injected tiny bubbles of air into the cornea to gently separate the various layers. Then each layer was subjected to electron microscopy to allow analysis to be performed at a vastly increased size.

It is thought that this discovery will help to further knowledge of a number of corneal diseases and in fact, the researchers of this work believe that a tear in Dua’s layer could be a reason for corneal hydrops, a bulging of the cornea through fluid build up in keratoconus patients.

Further information on this discovery can be found on the University of Nottingham's website here or the abstract may be found in Ophthalmology

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.